Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1 Vanessa L. Merker, B.S., Timothy P. Murphy, J. Bryan Hughes, B.A., Alona Muzikansky, M.A., Mark R. Hughes, M.D., Ph.D., Irene Souter, M.D., Scott R. Plotkin, M.D., Ph.D. Fertility and Sterility Volume 103, Issue 3, Pages 761-768.e1 (March 2015) DOI: 10.1016/j.fertnstert.2014.11.021 Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions
Figure 1 Diagnostic outcomes of preimplantation genetic diagnosis (PGD) for neurofibromatosis 1 (NF1). ∗Includes probe amplification failure or no molecular signal; ∗∗includes allele drop-out, conflicting marker data, multiple parental alleles observed, or recombination. Fertility and Sterility 2015 103, 761-768.e1DOI: (10.1016/j.fertnstert.2014.11.021) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions
Figure 2 Clinical outcomes after preimplantation genetic diagnosis (PGD) for neurofibromatosis 1. ∗Includes biochemical pregnancy, spontaneous abortion, and/or elective termination. Fertility and Sterility 2015 103, 761-768.e1DOI: (10.1016/j.fertnstert.2014.11.021) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions